Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study
- 5 August 1988
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 260 (5) , 641-651
- https://doi.org/10.1001/jama.260.5.641
Abstract
Research from JAMA — Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart StudyThis publication has 17 references indexed in Scilit:
- High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.Circulation, 1986
- Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham StudyJAMA, 1986
- High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.BMJ, 1986
- Fibrinogen: a possible link between social class and coronary heart disease.BMJ, 1985
- Mechanism of action of gemfibrozil on lipoprotein metabolism.Journal of Clinical Investigation, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.Circulation, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- THE LIPID RESEARCH CLINICS CORONARY PRIMARY PREVENTION TRIAL RESULTS .2. THE RELATIONSHIP OF REDUCTION IN INCIDENCE OF CORONARY HEART-DISEASE TO CHOLESTEROL LOWERING1984
- Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.Circulation, 1981